Covid-19 Resource Center

Covid-19 Resource Center

During these turbulent times, finding information is hard. The Quadax Resource Center will help keep you up to date on the latest COVID-19 topics, including laboratory testing, supply needs and payor and billing changes affecting reimbursement.

COVID-19 Payer Updates

Quadax is dedicated to keeping our clients up-to-date on the billing, reporting, and procedural information specific to each payer as it pertains to COVID-19.

Recent Blog Posts

Rising Expenses, Delta Variant Threatens Revenue Recovery

Recovery of hospital revenue to pre-pandemic levels is at risk according to a recent report from consultants Kaufman Hall. Rising expenses and increasing COVID hospitalizations threaten to reverse gains from the latter half of 2020 and the first half of 2021. In the current and ongoing state of uncertainty, it will be important for hospitals to have clear and current visibility into financial performance. Read on to learn how revenue cycle resiliency will further help to ensure hospitals are maximizing revenue, especially as margins remain thin and expenses high.

COVID-19 Articles, Bulletins, Town Halls, Webinars

Date

Article

Source

10/5/2021

COVID-19 Update

10/4/2021

FDA Authorizes Additional OTC Home Test to Increase Access to Rapid Testing for Consumers

10/4/2021

Lab Alert: Ellume Issues Voluntary Recall of Specific Lots of Ellume COVID-19 Home Tests

9/29/2021

New COVID-19 Vaccine Codes: September Update

9/24/2021

CMS Will Pay for COVID-19 Booster Shots, Eligible Consumers Can Receive at No Cost


9/22/2021

Lab Advisory: CDC Updates SARS-CoV-2 Variant Classifications

9/22/2021

FDA Authorizes Booster Dose of Pfizer-BioNTech COVID-19 Vaccine for Certain Populations

9/10/2021

COVID-19 Update

9/10/2021

HHS Announces the Availability of $25.5 Billion in COVID-19 Provider Funding

9/3/2021
AMA Announces Update to COVID-19 Vaccine CPT Codes

9/2/2021

Lab Advisory: Shortage of COVID-19 Rapid Tests May Increase Demand for Laboratory Testing

9/2/2021

Provider Enrollment Activities Resume in October

9/1/2021

FDA to Hold Advisory Committee Meeting to Discuss Pfizer-BioNTech’s Application for COVID-19 Booster

8/24/2021

CMS Expands Medicare Payments for At-Home COVID-19 Vaccinations

8/23/2021

FDA Approves First

COVID-19 Vaccine

8/18/2021

Joint Statement from

HHS Public Health and Medical Experts on

COVID-19 Booster Shots

8/9/2021

UPDATE: Lab Advisory 8/9/21: SARS-CoV-2 Variant Classification Updates

8/6/2021

Clinical Laboratory COVID-19 Response Call on Monday, August 23 at 3:00 PM ET

8/2/2021

Lab Alert: Clarifications about the Retirement of the CDC 2019 Novel Coronavirus (2019-nCov) Real-Time RT-PCR Diagnostic Panel

8/2/2021

Hospital Inpatient Prospective Payment System Final Rule Increases Payments to Treat COVID-19 and Improves Quality of Data Collection

7/30/2021

Coronavirus (COVID-19) Update

7/21/2021

Lab Alert: Changes to CDC RT-PCR for SARS-CoV-2 Testing

7/20/2021

Lab Advisory: SARS-CoV-2 Variant Classification Updates

7/18/2021

Lab Alert: FDA Revokes EUA for Curative SARS-CoV-2 Assay

7/15/2021

Lab Advisory: CDC Updates Pooling Guidance and Overview of Testing for SARS-CoV-2 Web Pages

7/13/2021

Revised fact sheets for the Johnson & Johnson (Janssen) COVID-19 Vaccine to include information pertaining to an observed increased risk of Guillain-Barré Syndrome (GBS) following vaccination.

7/8/2021

COVID-19 Snapshot: Impact on the Medicare Population

7/8/2021

COVID-19 Accelerated and Advance Payments: Updated FAQs. 

7/6/2021

Lab Advisory: SARS-CoV-2 Variants AY.1 and AY.2 Now Aggregated with Delta Variant B.1.617.2

6/30/2021

CDC Launches New COVID-19 Viral Testing Tool

6/29/2021

Lab Update: SARS-CoV-2 Variant Classification Changes

6/17/2021

CMS Infographic: Medicare Payment for COVID-19 Vaccination Administered in the Home

6/16/2021

CDC Updates Guidance for Reporting SARS-CoV-2 Sequencing Results.

6/15/2021

Coronavirus (COVID-19) Update

6/14/2021

Lab Alert: Sodium Citrate Blood Specimen Collection Tubes in Short Supply

6/14/2021

Lab Advisory: CDC Launches New COVID-19 Viral Testing Tool

6/10/2021

CMS increase provider payment for in-home COVID-19 vaccinations

6/9/2021

Biden Administration Continues Efforts to Increase Vaccinations by Bolstering Payments for At-Home COVID-19 Vaccinations for Medicare Beneficiaries

6/9/2021

HHS Secretary Xavier Becerra to Insurers & Providers: COVID-19 Vaccines and Testing Must be Free for Patients

5/28/2021

Lab Advisory: CDC Updates Testing Strategies for SARS-CoV-2 Web Page

5/25/2021

Coronavirus (COVID-19) Update: May 25, 2021

5/25/2021

HHS to Dedicate $4.8 Billion from American Rescue Plan to COVID-19 Testing for the Uninsured

5/21/2021

Coronavirus (COVID-19) Update: May 21, 2021

5/20/2021

Lab Advisory: CDC Updates NAATs and Self-Testing Web Pages

5/19/2021

Antibody Testing Is Not Currently Recommended to Assess Immunity After COVID-19 Vaccination: FDA Safety Communication

5/18/2021

CDC Updates Interim Guidance for Antigen Testing for SARS-CoV-2

5/5/2021

SARS-CoV-2 Variant Classifications and Definitions

5/3/2021

HHS Launches New Reimbursement Program for COVID-19 Vaccine Administration Fees not Covered by Insurance

4/26/2021

Time to Say Goodbye to Some Insurers’ Waivers for Covid Treatment Fees

4/21/2021

FDA Continues Important Steps to Ensure Quality, Safety and Effectiveness of Authorized COVID-19 Vaccines

4/20/2021

The FDA issued a pooling and serial testing amendment for many molecular diagnostic COVID-19 tests that had received an emergency use authorization (EUA) for testing individual samples.

4/16/2021

Medicare FFS Claims:
2% Payment Adjustment (Sequestration) Suspended Through December

4/15/2021

Message from HHS-OIG Leadership on the COVID-19 Vaccination Program and Provider Compliance

4/6/2021

The FDA issued an Emergency Use Authorization (EUA) to Symbiotica, Inc., for the COVID-19 Self-Collected Antibody Test System

4/2/2021

HHS Secretary Xavier Becerra Announces Expansion of COVID-19 Vaccine Program to All Community Health Centers Across the Country

4/2/2021

New web page posted: SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests for clinical laboratory staff and health care providers about the impact of viral mutations on COVID-19 molecular, antigen, and serology tests

4/1/2021

Repayment of COVID-19 Accelerated and Advance Payments Began on March 30, 2021

3/30/2021

Updated Serology EUA COVID-19 Templates Available

3/30/2021

New FDA web page - SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests - for clinical laboratory staff and health care providers about the impact of viral mutations on COVID-19 molecular tests

3/26/2021

FDA issues emergency use authorization (EUA) to the Twist Bioscience Corporation for their SARS-CoV-2 NGS Assay

3/26/2021

Lab Advisory: CDC Publishes New Web Page on Nucleic Acid Amplification Tests (NAATs)

3/22/2021

Lab Update: CMS Posts FAQ for Reporting Sequencing Results for SARS-CoV-2 Variants

3/15/2021

Medicare Payment Increase for COVID-19 Vaccine

3/13/2021

Lab Alert: FDA Issues Letter about Potential False Results with Roche cobas SARS-CoV-2 & Influenza Test

3/9/2021

Senate Passes $1.9 Trillion COVID-19 Bill; Several CAP-Backed Provisions Move Forward

3/9/2021

FDA issued an Emergency Use Authorization (EUA) to Cue Health Inc. for its over-the-counter at-home diagnostic test for COVID-19.

3/9/2021

Medicare Part B Payment for COVID-19 Vaccines and Certain Monoclonal Antibodies during the Public Health Emergency

3/5/2021

COVID-19 Update: FDA Issues Authorization for First Molecular Non-Prescription, At-Home Test

3/4/2021

COVID-19 Vaccine Administration: Insurance Coverage, MBI, & MSP

3/2/2021

Lab Advisory: FDA Issues New Guidance for Evaluating Impact of Viral Mutations on COVID-19 Tests

3/2/2021

COVID-19 Update: The agency issued an Emergency Use Authorization (EUA) to Quidel for its QuickVue At-Home COVID-19 Test for at-home use with a prescription

2/27/2021

House Approves Large COVID-19 Relief Bill; Includes $7.5 Billion for Vaccine Distribution

2/26/2021

Biden Administration Strengthens Requirements that Plans and Issuers Cover COVID-19 Diagnostic Testing Without Cost Sharing and Ensures Providers are Reimbursed for Administering COVID-19 Vaccines to Uninsured

2/26/2021

ACLA Statement on President Biden’s Actions to Close Coverage Gaps for COVID-19 Testing

2/12/2021

COVID-19 Update:  The FDA revised its guidance, Investigational COVID-19 Convalescent Plasma and associated web page, to reflect the reissued Emergency Use Authorization for COVID-19 convalescent plasma

2/11/2021

COVID-19: Revised Clinician Codes Accepted with CS Modifier

2/3/2021

COVID-19 Claims Reimbursement Program Update for the Uninsured

2/2/2021

Lab Advisory: CDC Publishes New Web Pages on Genomic Surveillance for SARS-CoV-2 Variants

1/29/2021

COVID-19 Update: The FDA has added content to the Q&A appendix in “Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency"

1/28/2021

HHS Announces Marketplace Special Enrollment Period for COVID-19 Public Health Emergency

1/21/2021

ACLA Statement on President Biden's Actions to Combat COVID-19

1/19/2021

Find your COVID-19 Vaccine CPT® Codes

1/8/2021

FDA Issues Alert Regarding SARS-CoV-2 Viral Mutation to Health Care Providers and Clinical Laboratory Staff

1/8/2021

Coronavirus (COVID-19) Update: January 8, 2021

1/4/2021

New ICD-10-CM code for the
2019 Novel Coronavirus (effective 1/1/21)

12/22/2020

Coronavirus (COVID-19) Update: December 22, 2020

12/19/2020

CMS Updates FAQs for CLIA Guidance during the COVID-19 Public Health Emergency

12/15/2020

FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine

12/15/2020

FDA Authorizes Antigen Test as First Over-the-Counter Fully At-Home Diagnostic Test for COVID-19

12/11/2020

COVID-19 and in vitro diagnostics: New market forces at play

12/10/2020

CMS offers guidance in billing Medicare for COVID-19 antibody treatment

12/10/2020

FAQs–Application of OIG's Administrative Enforcement Authorities to Arrangements Directly Connected to the Coronavirus Disease 2019 (COVID-19) Public Health Emergency

12/7/2020

Lab Advisory: CMS Revises Enforcement Discretion for SARS-CoV-2 Point-of-Care Tests

12/5/2020

Lab Update: CDC Updates SARS-CoV-2 Antigen Testing Guidance

12/3/2020

Lab Update: CDC Offers New COVID-19 Specimen Collection Infographics

12/4/2020

13 insurers extending COVID-19 cost-sharing waivers into 2021

12/3/2020

COVID-19 Frequently Asked Questions (FAQs) on Medicare Fee-for-Service (FFS) Billing

12/1/2020

Job Aids for Laboratory Professionals

12/1/2020

Clinical Laboratory COVID-19 Response Calls

11/24/2020

Guidance for SARS-CoV-2 Point-of-Care Testing

11/24/2020

Pathologists Advocate for Higher COVID-19 Payments During AMA Meeting

11/24/2020

A Closer Look at COVID-19 Diagnostic Testing

11/23/2020

2020 Clinical Lab & Pathology Resources

11/19/2020

HHS Launches Pilot Program of Fast Molecular POC Test for COVID-19

11/18/2020

Virtual Town Hall Series - Coronavirus (COVID-19) Test Development and Validation

11/18/2020

The FDA issued an EUA for the first COVID-19 diagnostic test for self-testing at home that provides rapid results

11/18/2020

The FDA published a new "FDA Insight" podcast titled: "Personal Protective Equipment and COVID-19"

11/17/2020

CAP Members Call on Congress to Stop Medicare Cuts

11/17/2020

CAP Asks CMS to Reduce COVID-19 Laboratory Reporting Burdens, Increase Testing Resources

11/11/2020

CMS Details Medicare Payment for New COVID-19 Antibody Drug

11/10/2020

AMA Announces Vaccine-Specific CPT Codes for COVID-19 Immunizations

11/9/2020

The FDA issued an emergency use authorization (EUA) for the investigational monoclonal antibody therapy bamlanivimab for the treatment of mild-to-moderate COVID-19 in adult and pediatric patients

11/2/2020

Clinical Laboratories Need Creative Staffing Strategies to Keep and Attract Hard-to-Find Medical Technologists, as Demand for COVID-19 Testing Increases